Detalhe da pesquisa
1.
A novel DNA methylation 10-CpG prognostic signature of disease-free survival reveal that MYBL2 is associated with high risk in prostate cancer.
Expert Rev Anticancer Ther
; 20(12): 1107-1119, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073649
2.
A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostate cancer.
Epigenomics
; 12(4): 333-352, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027524